RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+10.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$630M
AUM Growth
+$66.5M
(+12%)
Cap. Flow
+$17.9M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
120
New
23
Increased
22
Reduced
38
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 2 |
Merck
MRK
|
$12.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$12.4M |
| 4 |
AGN
Allergan plc
AGN
|
$6.33M |
| 5 |
UnitedHealth
UNH
|
$6.3M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$20M |
| 2 |
Pfizer
PFE
|
$13.2M |
| 3 |
Medtronic
MDT
|
$11M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$8.04M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
$8M |
Sector Composition
| 1 | Healthcare | 86.01% |
| 2 | Financials | 0.83% |
| 3 | Technology | 0.09% |
| 4 | Energy | 0.06% |
| 5 | Industrials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
26
DELISTED
Endo International plc
ENDP
| $7.26M | 1.15% |
360,200
-275,000
| -43% | -$5.54M |
|
27
Hologic
HOLX
$14.6B
| $6.99M | 1.11% |
180,000
| – | – |
|
28
Vertex Pharmaceuticals
VRTX
$102B
| $6.98M | 1.11% |
80,013
+20,013
| +33% | +$1.75M |
|
29
AbbVie
ABBV
$376B
| $6.94M | 1.1% |
110,000
+40,000
| +57% | +$2.52M |
|
30
Nektar Therapeutics
NKTR
$615M
| $6.7M | 1.06% |
26,000
-5,333
| -17% | -$1.37M |
|
31
Supernus Pharmaceuticals
SUPN
$2.54B
| $6.68M | 1.06% |
270,000
-10,000
| -4% | -$247K |
|
32
Edwards Lifesciences
EW
$47.7B
| $6.63M | 1.05% |
165,000
-45,000
| -21% | -$1.81M |
|
|
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.62M | 1.05% |
365,000
-5,000
| -1% | -$90.7K |
|
|
ZLTQ
34
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $6.28M | 1% |
160,000
| – | – |
|
35
DexCom
DXCM
$31.5B
| $5.7M | 0.91% |
260,000
+40,000
| +18% | +$877K |
|
|
ELGX
36
DELISTED
Endologix Inc
ELGX
| $5.57M | 0.88% |
43,500
| – | – |
|
37
Xencor
XNCR
$590M
| $5.51M | 0.88% |
225,000
| – | – |
|
38
Centene
CNC
$14B
| $5.36M | 0.85% |
160,000
-63,424
| -28% | -$2.12M |
|
39
Iovance Biotherapeutics
IOVA
$771M
| $5.35M | 0.85% |
650,000
| – | – |
|
|
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
| $5.24M | 0.83% |
65,000
-300
| -0.5% | -$24.2K |
|
|
NVRO
41
DELISTED
NEVRO CORP.
NVRO
| $5.15M | 0.82% |
49,300
-5,000
| -9% | -$522K |
|
42
Rigel Pharmaceuticals
RIGL
$686M
| $5.14M | 0.82% |
140,000
+55,000
| +65% | +$2.02M |
|
|
KITE
43
DELISTED
Kite Pharma, Inc.
KITE
| $5.03M | 0.8% |
90,000
+20,000
| +29% | +$1.12M |
|
|
AET
44
DELISTED
Aetna Inc
AET
| $4.85M | 0.77% |
42,000
-25,000
| -37% | -$2.89M |
|
45
Omnicell
OMCL
$1.51B
| $4.54M | 0.72% |
118,537
-10,000
| -8% | -$383K |
|
46
Humana
HUM
$37.5B
| $4.42M | 0.7% |
25,000
-5,000
| -17% | -$884K |
|
47
Cencora
COR
$57.2B
| $4.28M | 0.68% |
53,000
-25,000
| -32% | -$2.02M |
|
48
Cardinal Health
CAH
$35.7B
| $4.27M | 0.68% |
55,000
-27,000
| -33% | -$2.1M |
|
49
MacroGenics
MGNX
$116M
| $4.19M | 0.67% |
140,000
| – | – |
|
50
McKesson
MCK
$86.4B
| $4.17M | 0.66% |
25,000
-5,000
| -17% | -$834K |
|